MedTrace Logo

Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination

NCT02268162 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3228

Last updated 2015-11-16

No results posted yet for this study

Summary

This study evaluates the value of different bronchoscopy combination for diagnosing peripheral pulmonary lesions suspected to be cancer. One-third of participants will receive routine bronchoscopy, while one-third of participants will receive bronchoscopy combined with a guiding equipment and the other one-third of participants will receive bronchoscopy combined with two or more guiding equipments. These guiding equipments include virtual bronchoscopic navigation(VBN), endobronchial ultrasonography with a guide sheath(EBUS-GS) and fluoroscopy.

Conditions

  • Lung Neoplasms
  • Early Diagnosis
  • Bronchoscopy

Interventions

PROCEDURE

guiding equipments

The guiding equipments including VBN, EBUS-GS and fluoroscopy guide a bronchoscope along the bronchial route to a peripheral pulmonary lesion.

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER

  • Xinqiao Hospital of Chongqing

    collaborator OTHER

  • China Meitan General Hospital

    collaborator OTHER

  • Micro-Tech (Nanjing) Co., Ltd.

    collaborator INDUSTRY

  • Tang-Du Hospital

    lead OTHER

Principal Investigators

  • Faguang Jin, MD & PhD · Tang-Du Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02268162 on ClinicalTrials.gov